1-2 of 2
Antonio Galleu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in jaki-naïve myelofibrosis: Study rationale and preliminary patient characteristics

Free
Sebastian Grosicki, Haris Ali, Haifa Kathrin Al-Ali, Emanuele Ammatuna, Prithviraj Bose, Laura Gabriela Urian, Zhanet Grudeva-Popova, Valentín García Gutiérrez, Antonin Hlusi, Hsin-An Hou, Sung-Eun Lee, Michael Loschi, Jennifer O Sullivan, Andrea Patriarca, Raajit Rampal, Srinivas Tantravahi, Pankit Vachhani, Yi Chai, Pietro Taverna, Darko Miljkovic, Antonio Galleu, Von Potter, John Mascarenhas
Journal: Blood
Blood (2025) 146 (Supplement 1): 7353.
https://doi.org/10.1182/blood-2025-7353
Published: 2025
Journal Articles

An open-label, Phase 2 study of dapolsertib (MEN1703, SEL24) as monotherapy and in combination with glofitamab in patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

Free
Herve Ghesquieres, Malgorzata Krawczyk-Kulis, Dominik Chraniuk, Michal Kwiatek, Hendrik Nogai, Chadi Saba, Adam Falkowski, Katarzyna Kucharz, Michal Kulesza, Ruth Curley, Gary Wilkinson, Przemyslaw Juszczynski, Francesco Bertoni, Daniela Bellarosa, Antonio Galleu, Ira Gupta, Monika Dlugosz-Danecka, Wojciech Jurczak, Guillaume Cartron, Grzegorz Nowakowski
Journal: Blood
Blood (2025) 146 (Supplement 1): 5481.
https://doi.org/10.1182/blood-2025-5481
Published: 2025